Tekla Life Sciences Investors (HQL)
Company Info
Highlights
$398.47M
$3.04
4.67
$3.98M
$3.98M
$100.51M
$11.52 - $15.14
0.31
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in Tekla Life Sciences Investors, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Returns By Period
Tekla Life Sciences Investors had a return of 8.23% year-to-date (YTD) and 14.71% in the last 12 months. Over the past 10 years, Tekla Life Sciences Investors had an annualized return of 2.86%, while the S&P 500 had an annualized return of 11.31%, indicating that Tekla Life Sciences Investors did not perform as well as the benchmark.
HQL
8.23%
5.34%
-3.74%
14.71%
5.24%
2.86%
^GSPC (Benchmark)
4.46%
2.46%
9.31%
23.49%
13.03%
11.31%
Monthly Returns
The table below presents the monthly returns of HQL, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | 8.31% | 8.23% | |||||||||||
| 2024 | 1.93% | 2.62% | -0.44% | -4.03% | 5.44% | 6.38% | 8.47% | 1.62% | -0.33% | -3.45% | 1.49% | -7.99% | 11.03% |
| 2023 | 5.14% | -4.36% | -0.21% | 0.00% | -2.34% | 1.88% | -0.67% | -0.91% | -4.15% | -7.06% | 5.71% | 12.64% | 4.23% |
| 2022 | -5.62% | -7.06% | 0.42% | -6.35% | -3.63% | -2.33% | 4.85% | -1.25% | -5.40% | 7.25% | 5.11% | -5.77% | -19.21% |
| 2021 | 2.78% | 4.98% | -5.65% | 4.01% | -0.75% | 7.58% | -2.98% | 7.08% | -4.81% | 2.26% | -4.77% | -3.07% | 5.52% |
| 2020 | -5.05% | -1.82% | -5.67% | 13.75% | 6.48% | 0.90% | -0.28% | 1.89% | -1.40% | -3.87% | 13.07% | 5.72% | 23.72% |
| 2019 | 15.69% | 2.24% | -2.34% | -4.15% | -3.13% | 8.43% | -2.61% | -3.24% | -2.64% | 5.23% | 9.95% | 1.69% | 25.53% |
| 2018 | 4.13% | -3.82% | -0.26% | -3.33% | 3.07% | 0.21% | 4.52% | 6.37% | -0.29% | -13.17% | 2.21% | -14.59% | -16.18% |
| 2017 | 5.18% | 7.17% | 3.25% | 5.72% | -1.61% | 5.52% | 3.40% | 2.80% | -1.10% | -5.31% | -4.92% | 3.81% | 25.51% |
| 2016 | -23.18% | -3.88% | 5.65% | 3.98% | 4.81% | -6.24% | 10.94% | -2.20% | 0.43% | -10.57% | 7.60% | -3.63% | -19.46% |
| 2015 | 8.64% | 5.81% | -1.89% | -4.32% | 7.08% | 1.80% | 5.85% | -8.33% | -15.82% | 15.77% | -0.66% | -4.28% | 5.77% |
| 2014 | 3.87% | 16.77% | -10.75% | -4.41% | -0.08% | 1.91% | 1.83% | 8.45% | -1.69% | 9.19% | 5.88% | -0.72% | 31.29% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
The current rank of HQL is 69, indicating average performance compared to other stocks on our website. Here’s a breakdown of how it compares using common performance measures.
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for Tekla Life Sciences Investors (HQL) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Dividends
Dividend History
Tekla Life Sciences Investors provided a 10.35% dividend yield over the last twelve months, with an annual payout of $1.47 per share.
| Period | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend | $1.47 | $1.86 | $1.27 | $1.36 | $1.69 | $1.56 | $1.40 | $1.62 | $1.62 | $2.07 | $2.80 | $1.77 |
Dividend yield | 10.35% | 14.18% | 9.44% | 9.57% | 8.79% | 7.90% | 8.03% | 10.72% | 8.25% | 12.18% | 11.84% | 7.11% |
Monthly Dividends
The table displays the monthly dividend distributions for Tekla Life Sciences Investors. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | $0.00 | $0.00 | $0.00 | ||||||||||
| 2024 | $0.00 | $0.39 | $0.00 | $0.00 | $0.48 | $0.00 | $0.00 | $0.49 | $0.00 | $0.00 | $0.50 | $0.00 | $1.86 |
| 2023 | $0.00 | $0.33 | $0.00 | $0.00 | $0.32 | $0.00 | $0.00 | $0.32 | $0.00 | $0.00 | $0.30 | $0.00 | $1.27 |
| 2022 | $0.00 | $0.39 | $0.00 | $0.00 | $0.35 | $0.00 | $0.00 | $0.31 | $0.00 | $0.00 | $0.31 | $0.00 | $1.36 |
| 2021 | $0.00 | $0.43 | $0.00 | $0.00 | $0.41 | $0.00 | $0.00 | $0.43 | $0.00 | $0.00 | $0.42 | $0.00 | $1.69 |
| 2020 | $0.00 | $0.39 | $0.00 | $0.00 | $0.34 | $0.00 | $0.00 | $0.41 | $0.00 | $0.00 | $0.40 | $0.02 | $1.56 |
| 2019 | $0.00 | $0.33 | $0.00 | $0.00 | $0.37 | $0.00 | $0.00 | $0.37 | $0.00 | $0.00 | $0.33 | $0.00 | $1.40 |
| 2018 | $0.00 | $0.40 | $0.00 | $0.00 | $0.40 | $0.00 | $0.00 | $0.40 | $0.00 | $0.00 | $0.42 | $0.00 | $1.62 |
| 2017 | $0.00 | $0.36 | $0.00 | $0.00 | $0.41 | $0.00 | $0.00 | $0.42 | $0.00 | $0.00 | $0.43 | $0.00 | $1.62 |
| 2016 | $0.00 | $0.48 | $0.00 | $0.37 | $0.00 | $0.82 | $0.00 | $0.00 | $0.00 | $0.00 | $0.40 | $0.00 | $2.07 |
| 2015 | $0.00 | $0.50 | $0.00 | $0.00 | $0.54 | $0.00 | $0.00 | $0.58 | $0.00 | $0.00 | $0.47 | $0.71 | $2.80 |
| 2014 | $0.42 | $0.00 | $0.00 | $0.43 | $0.00 | $0.00 | $0.45 | $0.00 | $0.00 | $0.47 | $0.00 | $1.77 |
Dividend Yield & Payout
Dividend Yield
Payout Ratio
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Worst Drawdowns
The table below displays the maximum drawdowns of the Tekla Life Sciences Investors. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Tekla Life Sciences Investors was 61.70%, occurring on Oct 9, 2002. Recovery took 2340 trading sessions.
The current Tekla Life Sciences Investors drawdown is 10.67%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -61.7% | Feb 22, 2000 | 661 | Oct 9, 2002 | 2340 | Jan 25, 2012 | 3001 |
| -48.41% | Dec 10, 1992 | 506 | Dec 9, 1994 | 283 | Jan 24, 1996 | 789 |
| -45.17% | Jul 24, 2015 | 140 | Feb 11, 2016 | 1206 | Nov 27, 2020 | 1346 |
| -40.7% | Oct 8, 1997 | 253 | Oct 8, 1998 | 219 | Aug 23, 1999 | 472 |
| -38.86% | Sep 8, 2021 | 538 | Oct 27, 2023 | — | — | — |
Volatility
Volatility Chart
The current Tekla Life Sciences Investors volatility is 4.67%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.
Financials
Financial Performance
Valuation
The Valuation section provides an assessment of the market value of Tekla Life Sciences Investors compared to its peers in the Asset Management industry.
PE Ratio
The chart displays the price to earnings (P/E) ratio for HQL in comparison to other companies of the Asset Management industry. Currently, HQL has a PE value of 4.7. This PE value is considered to be low compared to the rest of the industry.PEG Ratio
The chart displays the price to earnings to growth (PEG) ratio for HQL in comparison to other companies of the Asset Management industry. Currently, HQL has a PEG value of 0.0. This PEG ratio is much higher than those of other companies of the industry. This might be an indicator of the company being overvalued.Historical P/E Ratio Chart
The chart below displays the historical trend of the price-to-earnings (P/E) ratio for Tekla Life Sciences Investors.
Loading data...
Income Statement
| TTM | |
|---|---|
Revenue | |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |